Volume 14, Number 9—September 2008
Circulation of 3 Lineages of a Novel Saffold Cardiovirus in Humans
|ID no.||Sequence (5′ → 3′)||Position†||Orientation||Usage|
|CF188||CTAATCAGAGGAAAGTCAGCAT||188–209||+||Nested RT-PCR, 1st round‡|
|CF204||CAGCATTTTCCGGCCCAGGCTAA||204–226||+||Nested RT-PCR, 2nd round§|
|CR718||GCTATTGTGAGGTCGCTACAGCTGT||718–742||–||Nested RT-PCR, 2nd round§|
|CR990||GACCACTTGGTTTGGAGAAGCT||990–1011||–||Nested RT-PCR, 1st round‡|
|CP797||FAM-AGATCCACTGCTGTGAGCGGTGCAA-BHQ1||797–821||+ (probe)||Real-time PCR¶|
*ID, identification; RT-PCR, reverse transcription–PCR; FAM, 6-carboxyfluorescein; BHQ1, black hole quencher 1.
†Relative to Saffold virus EF165067 genome.
‡25-µL reactions used the QIAGEN OneStep RT-PCR kit (QIAGEN, Hilden, Germany), with 400 nmol/L each of 1st-round primers CF188 and CR990, 1 µL enzyme mix, 1 µg bovine serum albumin, and 5 µL RNA extract. Amplification involved 30 min at 50°C; 15 min at 95°C; 10 cycles of 20 s at 94°C, 30 s starting at 60°C with a decrease of 1°C per cycle, and 50 s at 72°C; and 40 cycles of 20 s at 95°C, 30 s at 54°C, and 50 s at 72°C with a final elongation step of 5 min at 72°C.
§50-µL reactions used 1 µL of 1st-round PCR product, with 1x Platinum Taq buffer (Invitrogen, Karlsruhe, Germany), 200 µmol/L deoxynucleoside triphosphates each, 2.5 mmol/L MgCl2, 400 nmol/L each of 2nd-round primers CF204 and CR718, and 1 U Platinum Taq polymerase. Amplification involved 3 min at 94°C and 45 cycles of 20 s at 94°C, 30 s at 60°C, and 40 s at 72°C.
¶25-µL reactions used 3 µL of RNA extract, 1x reaction buffer and enzymes from the QIAGEN OneStep RT-PCR kit, 600 nM of primer CF723, 400 nM of primer CR888, and 160 nM of probe CP797. Cycling in an Applied Biosystems 7700 SDS instrument involved the following steps: 55°C for 15 min, 95°C for 15 min, and 45 cycles of 95°C for 15 s/58°C for 30 s.
- Page created: July 13, 2010
- Page last updated: July 13, 2010
- Page last reviewed: July 13, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)